Domů › Rakovina prostaty › Pennsylvania › Pittsburgh
Klinické studie Rakovina prostaty v Pittsburgh, PA
23 studií pro Rakovina prostaty hledá účastníky v lokalitách v Pittsburgh a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Probíhá náborFáze 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · Vzdálenost 11 mi
- a dalších 3
Distance-Based Exercise to Preserve Function and Prevent Disability
Probíhá nábor
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Probíhá náborFáze 2
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- a dalších 2
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Probíhá náborFáze 1
- University of Pittsburgh Medical Center, Pittsburgh
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Probíhá náborFáze 3
- University of Pittsburgh Medical Center, Pittsburgh
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Probíhá náborFáze 3
- Research Site, Pittsburgh
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Probíhá náborFáze 1
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Probíhá náborFáze 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- a dalších 6
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Probíhá náborFáze 3
- Research Site, Pittsburgh
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Probíhá náborFáze 1
- University of Pittsburgh Medical Center, Pittsburgh
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Probíhá náborFáze 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- a dalších 9
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Probíhá náborFáze 1
- UPMC Hillman Cancer Center, Pittsburgh
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Probíhá náborFáze 1
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Probíhá náborFáze 1
- University of Pittsburg Medical Center (UPCM), Pittsburgh
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Probíhá náborFáze 1
- UPMC Hillman Cancer Center, Pittsburgh
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Probíhá náborFáze 4
- Univ of Pittsburgh Medical Center, Pittsburgh
TERPS Trial for de Novo Oligometastic Prostate Cancer
Probíhá náborFáze 2
- UPMC Hillman Cancer Center, Pittsburgh
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Probíhá náborFáze 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · Vzdálenost 11 mi
- a dalších 2
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Probíhá náborObservační studie
- Allegheny Health Network, Pittsburgh
Circulating Tumor DNA in High Risk Localized Prostate Cancer
Probíhá náborObservační studie
- UPMC Hillman Cancer Center, Pittsburgh
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Probíhá náborFáze 3
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- UPMC-Shadyside Hospital, Pittsburgh
Studie Rakovina prostaty v jiných městech
- New York City, NY103 studií
- Houston, TX76 studií
- Los Angeles, CA61 studií
- Boston, MA59 studií
- St. Louis, MO46 studií
- Chicago, IL45 studií
- San Francisco, CA45 studií
- Philadelphia, PA44 studií
- Baltimore, MD43 studií
- Nashville, TN42 studií
- Seattle, WA42 studií
- Washington, DC38 studií
Další studie v Pittsburgh
- Nemalobuněčný plicní karcinom48 studií
- Rakovina (všechny typy)41 studií
- Rakovina prsu39 studií
- Kolorektální karcinom32 studií
- Metastatický karcinom31 studií
- Melanom31 studií
- Rakovina vaječníků30 studií
- Rakovina endometria23 studií
- Rakovina plic23 studií
- Mrtvice22 studií
- Squamózní buněčný karcinom hlavy a krku22 studií
- Deprese22 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.